New capital will accelerate market expansion, partnerships, and product development to improve dental care for millions of patients January 29, 2025 07:31 PM Eastern Standard Time BOSTON–(BUSINESS WIRE)–VideaHealth, the leading dental AI company, today announced…
January 30, 2025 08:00 AM Eastern Standard Time BOSTON–(BUSINESS WIRE)–Freeze Inc., a leading provider of proactive offensive security and attack surface protection solutions designed to prevent hackers from gaining the necessary information and resources to…
According to filings with the U.S. Securities and Exchange Commission, Valid is raising up to $6,861,790.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold securities…
According to filings with the U.S. Securities and Exchange Commission, Microbot Medical is raising up to $7,000,000.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold…
According to filings with the U.S. Securities and Exchange Commission, Elevate Youth Development is raising up to $15,000,000.00 in new funding. The federal securities law requires the notice to be filed by companies that have…
Boston, Massachusetts — According to state and local development sources, Breaktime plans to invest $6,300,000.00 to build out new space in Boston. The company plans to occupy the new space at 63 Franklin St in…
Capital and resources will further drive product innovation and grow the company’s global customer base BOSTON, Jan. 7, 2025 /PRNewswire/ — Northern Light Group, the leading enterprise knowledge management platform for competitive intelligence and market research, today announced…
Financing co-led by Samsara Biocapital and Enavate Sciences, with participation from Pfizer Ventures and Regeneron Ventures in addition to other new and existing investors Normunity’s lead program is a novel T cell engager against a…
$17M Series B Round Led by Aquiline to FuelScripta’s Growth into Health Plan and Medicare Advantage Markets BOSTON, Dec. 18, 2024 /PRNewswire/ — “Consumerism in healthcare” is a popular catch phrase, but when it comes to prescription drugs, Americans are…
LONDON and BOSTON, Dec. 19, 2024 /PRNewswire/ — Ottimo Pharma (“Ottimo”), a private biotech company pioneering bifunctional medicines to extend the lives of people living with cancer, today announces the completion of a Series A financing round of over $140…